CI
Celularity Inc
SEC filingBiotechnology · Florham Park, NJ
Amount raised$2Msold at filing
Total offering$6.7M$4.7M still open
Investors in the raise1count reported to the SEC
FiledNov 3, 2025first sale Oct 24, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Diane A. ParksDirector
Peter A. DiamandisDirector
John R. HainesExecutive Officer
Vincent A. LeVienDirector
Joseph R. DosSantosExecutive Officer
Robert J. HaririExecutive Officer, Director
Geoffrey A. LingDirector
Stephen A. BrigidoExecutive Officer
Executive officers, directors and promoters as listed on the Form D.